Rick Randall landed his first job in Medtech on a bet. Today, he’s one of the sector’s most experienced CEOs. In the first part of a two-part interview with Medtech Talk, Randall, the CEO of OMNIlife…
Serial innovator Mark Blumenkranz, MD, who last year moved into an emeritus position at Stanford, shares his enthusiasm and concerns for the future of innovation in the US.
For more than a decade, Lisa Suennen, Senior Managing Director, healthcare at GE Ventures and Managing Partner at Venture Valkyrie, LLC, has blogged and opined on the healthcare industry. In this pod…
Nim Shah left Domain Associates to take on the chief business officer role at hot Start-Up Fractyl Laboratories. Hear why he made the change, what he feels went wrong for Medtech, and what’s next for…
Ryan Egeland, senior director, business development & licensing at Medtronic, is searching for tech and start-ups that bolster the Medtech giant’s surgical innovations group.
Kirk Nielsen’s path to Versant passed through thoughts of medical school, a short stint in the NHL, and a span at Medtronic. Today, Nielsen represents the global VC’s interests in Medtech, serving as…
Trod Founder and CEO Andre Faure tells the tale of Trod, a low-capital-burning start-up focused on introducing a next-generation of ablation tools to treat the prostate and other soft tissue.
You can’t be involved in as many successful start-ups as Tom Ressemann and not walk away with great lessons and valuable experiences. The former Entellus founder and CEO examines the wins and challen…
Zeshan Muhammedi thinks he and his co-founders of FundRx have identified some “misalignments” in funding Medtechs. The solution may be FundRx, a new breed of venture capital firm bringing LPs, KOLs, …
Long ago, Tony Arnold wondered how he might find an opening in Medtech. Today, he’s leading one of the sector’s most novel start-ups, SetPoint Medical, which is using the nervous system to ease infla…
Lisa Wipperman Heine, COO of Mitralign, says the FDA is making quicker work of review times. But the same might not be said for other countries where Medtechs once had a faster time to market. In thi…
Steve Clark, senior vice president at Optum Life Sciences, says healthcare rests in the “nascent” stages of questioning effectiveness of medical tech. Successful start-ups will find the right answer…
Jerry Harrison, rock star turned investor, joined with former Wall Streeter Brian A. Smith to create Red Crow to build a platform for healthcare start-ups to tap the “crowd” as a new source of capita…
Medtech Conference co-chair Stacy Enxing Seng, after succeeding at both start-ups and corporates, shares her enthusiasm for her new role as venture partner at Lightstone Ventures.
Medtech Conference co-chair Kevin Hykes revisits his days at Visiogen and Cameron Health, explaining how those successful outcomes help guide his hand on Metavention’s tiller.
Last month, a surgeon performed ophthalmology’s first robot-assisted surgery – a membrane peel. Marc de Smet, chief medical officer of Preceyes, a Dutch start-up, shares the company’s history and pla…
Backed by nearly $30 million from the Department of Defense, BrainScope created a device to make concussion diagnosis more certain. Hear what’s next for the Medtech start-up.
Ashley McEvoy, Company Group Chairman, Johnson & Johnson Vision Care and Johnson & Johnson Diabetes Care Companies, says the new force could pursue M&A in future expansion. Hear the details of the de…
Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.
Disclaimer: The podcast and artwork embedded on this page are the property of Healthegy. This content is not affiliated with or endorsed by eachpod.com.